The Efficacy of Cabazitaxel in Treating Prostate Cancer: A Systematic Review and Meta-Analysis

Cabazitaxel, a second-generation taxane chemotherapy agent, has demonstrated efficacy in treating metastatic castration-resistant prostate cancer (mCRPC) in patients who have previously received docetaxel-based therapy. By targeting microtubule dynamics, cabazitaxel inhibits cancer cell division and...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hashim Talib Hashim, Mudassir Ahmad Khan, Safa Irfan Shah, Mohammedbaqer Ali Al-Ghuraibawi, Fatimah Abdullah Sulaiman, Jamil Nasrallah, Ralph Maroun, Ali Talib Hashim, Naseer Ahmed, Zahraa Hamaza Merza
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2024-10-01
Col·lecció:	American Journal of Men's Health
Accés en línia:	https://doi.org/10.1177/15579883241285162
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!